100 related articles for article (PubMed ID: 11137984)
21. The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?
Silva AL; Romão L
FEBS Lett; 2009 Feb; 583(3):499-505. PubMed ID: 19162024
[TBL] [Abstract][Full Text] [Related]
22. Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome.
Beltcheva O; Martin P; Lenkkeri U; Tryggvason K
Hum Mutat; 2001 May; 17(5):368-73. PubMed ID: 11317351
[TBL] [Abstract][Full Text] [Related]
23. Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model.
Yang Y; Swaminathan S; Martin BK; Sharan SK
Hum Mol Genet; 2003 Sep; 12(17):2121-31. PubMed ID: 12915465
[TBL] [Abstract][Full Text] [Related]
24. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
[TBL] [Abstract][Full Text] [Related]
25. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
26. The double-RNA-specific adenosine deaminase (DSRAD) gene in dyschromatosis symmetrica hereditaria patients: two novel mutations and one previously described.
Sun XK; Xu AE; Chen JF; Tang X
Br J Dermatol; 2005 Aug; 153(2):342-5. PubMed ID: 16086746
[TBL] [Abstract][Full Text] [Related]
27. Features of missense/nonsense mutations in exonic splicing enhancer sequences from cancer-related human genes.
Jin P; Cai R; Zhou X; Li-Ling J; Ma F
Mutat Res; 2012 Dec; 740(1-2):6-12. PubMed ID: 23123687
[TBL] [Abstract][Full Text] [Related]
28. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
29. GDAP1 mutations in Czech families with early-onset CMT.
Baránková L; Vyhnálková E; Züchner S; Mazanec R; Sakmaryová I; Vondrácek P; Merlini L; Bojar M; Nelis E; De Jonghe P; Seeman P
Neuromuscul Disord; 2007 Jun; 17(6):482-9. PubMed ID: 17433678
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM+ defect.
Guella I; Soldà G; Spena S; Asselta R; Ghiotto R; Tenchini ML; Castaman G; Duga S
Thromb Haemost; 2008 Mar; 99(3):523-30. PubMed ID: 18327400
[TBL] [Abstract][Full Text] [Related]
31. Are splicing mutations the most frequent cause of hereditary disease?
López-Bigas N; Audit B; Ouzounis C; Parra G; Guigó R
FEBS Lett; 2005 Mar; 579(9):1900-3. PubMed ID: 15792793
[TBL] [Abstract][Full Text] [Related]
32. Missense and nonsense mutations in the alternatively-spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome.
McAlinden A; Majava M; Bishop PN; Perveen R; Black GC; Pierpont ME; Ala-Kokko L; Männikkö M
Hum Mutat; 2008 Jan; 29(1):83-90. PubMed ID: 17721977
[TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene.
Sergi C; Penzel R; Uhl J; Zoubaa S; Dietrich H; Decker N; Rieger P; Kopitz J; Otto HF; Kiessling M; Cantz M
Hum Genet; 2001 Oct; 109(4):421-8. PubMed ID: 11702224
[TBL] [Abstract][Full Text] [Related]
34. Exon-exon junction--what's your function?
Hood J
Trends Cell Biol; 2001 Dec; 11(12):463. PubMed ID: 11719040
[No Abstract] [Full Text] [Related]
35. Mutations in the factor XI gene.
Savidge G; Smith M
Am J Hematol; 2001 Jan; 66(1):67. PubMed ID: 11426499
[No Abstract] [Full Text] [Related]
36. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
Vaziri SA; Krumroy LM; Rostai M; Casey G
Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249
[TBL] [Abstract][Full Text] [Related]
37. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
[TBL] [Abstract][Full Text] [Related]
38. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
[TBL] [Abstract][Full Text] [Related]
39. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
40. A change in the last base of BRCA1 exon 23, 5586G-->A, results in abnormal RNA splicing.
Ladopoulou A; Konstantopoulou I; Armaou S; Efstathiou E; Mihalatos M; Nasioulas G; Bardi G; Pandis N; Yannoukakos D; Athens ;
Cancer Genet Cytogenet; 2002 Apr; 134(2):175-7. PubMed ID: 12034536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
